Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CNO Financial Group’s SEC disclosures are dense with actuarial tables, reserve calculations and investment schedules—essential data that can overwhelm even seasoned analysts. If you’ve ever wondered where in a 300-page document the risk-based capital ratio or Bankers Life claim reserves are buried, you know the challenge of decoding “CNO SEC filings explained simply.”
Stock Titan solves this problem. Our AI reads every CNO quarterly earnings report 10-Q filing, CNO annual report 10-K simplified, and CNO 8-K material events explained the moment they post to EDGAR, then delivers concise summaries, ratio tables and trend charts. Need CNO insider trading Form 4 transactions or alerts on CNO Form 4 insider transactions real-time? We flag executive stock moves before most screens refresh. Curious about dividends or portfolio shifts? Our AI highlights them while linking directly to the relevant page of the filing, so you can focus on decisions, not document hunts.
Because CNO’s business depends on long-duration liabilities, investors track interest-rate sensitivity, segment margins and statutory capital. Our coverage connects each form to the insight it unlocks: 10-K footnotes reveal credit quality of the 40|86 Advisors portfolio; 10-Q MD&A shows changes in health loss ratios; 8-K breaks down reinsurance transactions; the proxy details CNO proxy statement executive compensation. Use our platform to monitor CNO executive stock transactions Form 4, dive into CNO earnings report filing analysis, and get context for every material event. That’s understanding CNO SEC documents with AI—saving hours and improving clarity.
CNO Financial Group Form 144 discloses a proposed sale of common stock: 9,920 shares with an aggregate market value of $376,551.30, to be executed on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. The filing records 96,931,934 shares outstanding.
The shares were acquired from the issuer on 02/15/2024 as performance shares and payment is shown as Not Applicable. The filer reports Nothing to Report for securities sold during the past three months and makes the standard representation that they are not aware of undisclosed material adverse information about the issuer.
Form 144 notice for CNO Financial Group (CNO) reports a proposed sale of 6,420 common shares with an aggregate market value of $243,702.56. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. Total shares outstanding reported are 96,931,934, giving readers the raw figures needed to assess scale.
The filing shows how the securities were acquired: 2,000 shares were restricted stock granted on 08/09/2024 and 4,420 were from a stock option exercise on 08/13/2025 paid in cash. The filer reports no sales in the past three months.
CNO Financial Group filed a Form S-8 to register an additional 2,000,000 shares of common stock for issuance under its Amended and Restated Long-Term Incentive Plan. The board adopted the amendment on February 12, 2025 and stockholders approved it on May 8, 2025. The amendment increases the number of shares reserved and the number of incentive stock options that may be granted by 2,000,000 shares and extends the plan termination to the day immediately prior to the tenth anniversary of stockholder approval.
The filing omits Part I prospectus text under Rule 428 and incorporates prior S-8 registration statements and recent Exchange Act filings by reference, including the Annual Report for the year ended December 31, 2024 (filed February 26, 2025) and quarterly reports filed May 7, 2025 and August 6, 2025.
CNO Financial Group, Inc. filed a Form S-8 to register an additional 1,600,000 shares of its common stock for issuance under the Amended and Restated Employee Stock Purchase Plan. The board adopted the amendment and restatement of the Plan on February 12, 2025, and the company’s stockholders approved the amendment on May 8, 2025. The additional shares increase the number of shares reserved for the Plan relative to the shares previously registered under the company’s prior Form S-8 (File No. 333-224819).
The Registration Statement incorporates by reference the company’s recent annual and quarterly reports and specified current reports, and it describes the company’s Delaware-based indemnification provisions and directors’ and officers’ insurance. The filing lists key exhibits, including the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws, the ESPP document incorporated by reference, legal opinions and consents.
FAQ
What is the current stock price of Cno Finl Group (CNO)?
What is the market cap of Cno Finl Group (CNO)?
